PYCR2

pyrroline-5-carboxylate reductase 2, the group of MicroRNA protein coding host genes

Basic information

Region (hg38): 1:225919877-225924340

Links

ENSG00000143811NCBI:29920OMIM:616406HGNC:30262Uniprot:Q96C36AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • autosomal recessive primary microcephaly (Supportive), mode of inheritance: AR
  • hypomyelinating leukodystrophy 10 (Definitive), mode of inheritance: AR
  • hypomyelinating leukodystrophy 10 (Strong), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Leukodystrophy, hypomyelinating 10ARGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingCraniofacial; Musculoskeletal; Neurologic25865492

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the PYCR2 gene.

  • not provided (5 variants)
  • Hypomyelinating leukodystrophy 10 (2 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the PYCR2 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
1
clinvar
26
clinvar
3
clinvar
30
missense
7
clinvar
36
clinvar
1
clinvar
44
nonsense
2
clinvar
1
clinvar
1
clinvar
4
start loss
2
clinvar
2
frameshift
3
clinvar
3
clinvar
6
inframe indel
1
clinvar
1
splice donor/acceptor (+/-2bp)
1
clinvar
4
clinvar
5
splice region
1
3
1
5
non coding
1
clinvar
8
clinvar
3
clinvar
12
Total 6 15 42 34 7

Highest pathogenic variant AF is 0.0000263

Variants in PYCR2

This is a list of pathogenic ClinVar variants found in the PYCR2 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
1-225920477-G-C not specified Benign (Apr 10, 2023)730211
1-225920494-G-C not specified • Hypomyelinating leukodystrophy 10 Benign/Likely benign (Jan 08, 2024)770123
1-225920500-C-T Benign (Jan 29, 2024)1166246
1-225920520-G-C Inborn genetic diseases Uncertain significance (Jan 27, 2022)2274359
1-225920541-C-A Uncertain significance (Aug 02, 2022)2201453
1-225920552-C-T Inborn genetic diseases Uncertain significance (Dec 03, 2021)2356229
1-225920577-C-T Inborn genetic diseases Uncertain significance (Jun 03, 2024)3311861
1-225920601-C-G Uncertain significance (Jul 15, 2022)1713832
1-225920617-C-T Likely benign (Sep 01, 2022)1571197
1-225921192-C-T Uncertain significance (Dec 02, 2021)1345608
1-225921194-C-T Hypomyelinating leukodystrophy 10 Benign (Jan 30, 2024)1166899
1-225921199-T-G Hypomyelinating leukodystrophy 10 Benign (Jan 30, 2024)1167877
1-225921209-G-A Hypomyelinating leukodystrophy 10 Pathogenic (Sep 01, 2022)254247
1-225921219-A-C Uncertain significance (Sep 07, 2022)2113420
1-225921220-CAGG-C Uncertain significance (Dec 08, 2021)2202991
1-225921232-A-G Hypomyelinating leukodystrophy 10 Likely pathogenic (Mar 20, 2024)254248
1-225921243-G-A Likely benign (Nov 29, 2017)729355
1-225921246-C-CAG Hypomyelinating leukodystrophy 10 Pathogenic/Likely pathogenic (Nov 13, 2023)286401
1-225921253-C-T Hypomyelinating leukodystrophy 10 Conflicting classifications of pathogenicity (-)992853
1-225921254-G-A Hypomyelinating leukodystrophy 10 Pathogenic (May 07, 2015)192394
1-225921257-A-C Hypomyelinating leukodystrophy 10 Uncertain significance (May 21, 2021)2435308
1-225921258-G-A Likely benign (Jul 17, 2023)1923478
1-225921260-C-G Uncertain significance (Jun 05, 2022)1377258
1-225921294-G-T Likely benign (Apr 10, 2022)2068504
1-225921311-A-C Hypomyelinating leukodystrophy 10 Pathogenic (Sep 16, 2016)254250

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
PYCR2protein_codingprotein_codingENST00000343818 74401
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.000002070.4761257200281257480.000111
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.9481561930.8080.00001092053
Missense in Polyphen3461.0790.55665639
Synonymous-0.5209285.91.070.00000542691
Loss of Function0.6851012.60.7927.21e-7135

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0007290.000728
Ashkenazi Jewish0.000.00
East Asian0.00005440.0000544
Finnish0.0001390.000139
European (Non-Finnish)0.00006190.0000615
Middle Eastern0.00005440.0000544
South Asian0.00006530.0000653
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Housekeeping enzyme that catalyzes the last step in proline biosynthesis. In some cell types, such as erythrocytes, its primary function may be the generation of NADP(+). Can utilize both NAD and NADP. Has higher affinity for NADP, but higher catalytic efficiency with NADH (PubMed:2722838, PubMed:6894153). Involved in cellular response to oxidative stress (PubMed:25865492). {ECO:0000269|PubMed:25865492, ECO:0000269|PubMed:2722838, ECO:0000269|PubMed:6894153}.;
Pathway
Arginine and proline metabolism - Homo sapiens (human);Hyperornithinemia with gyrate atrophy (HOGA);Creatine deficiency, guanidinoacetate methyltransferase deficiency;L-arginine:glycine amidinotransferase deficiency;Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome];Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency);Prolinemia Type II;Prolidase Deficiency (PD);Arginine and Proline Metabolism;Hyperprolinemia Type I;Hyperprolinemia Type II;Ornithine Aminotransferase Deficiency (OAT Deficiency);Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency);Metabolism of amino acids and derivatives;Metabolism;proline biosynthesis;Amino acid synthesis and interconversion (transamination) (Consensus)

Recessive Scores

pRec
0.162

Intolerance Scores

loftool
0.338
rvis_EVS
-0.71
rvis_percentile_EVS
14.4

Haploinsufficiency Scores

pHI
0.201
hipred
N
hipred_score
0.146
ghis
0.618

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.969

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Pycr2
Phenotype
immune system phenotype; hematopoietic system phenotype;

Gene ontology

Biological process
proline biosynthetic process;cellular amino acid biosynthetic process;cellular response to oxidative stress;oxidation-reduction process;L-proline biosynthetic process
Cellular component
mitochondrion;mitochondrial matrix
Molecular function
pyrroline-5-carboxylate reductase activity;protein binding